Publications
- Early MRD response as a prognostic factor in adult patients with acute lymphoblastic leukemia2016 | Second Faculty of Medicine
- Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia2013 | Second Faculty of Medicine
- Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR/ABL-positive ALL: implications for residual disease monitoring2009 | Second Faculty of Medicine
- Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?2008 | Second Faculty of Medicine
- Molecular Screening in ALK-Positive Anaplastic Large Cell Lymphoma: ALK Analysis, NGS Fusion Gene Detection, and T-cell Receptor Immunoprofiling2024 | Second Faculty of Medicine, Third Faculty of Medicine
- Treatment of adult patients with acute lymphoblastic leukemia in the Czech Republic in the period 2007–20202023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- IL-17 driven induction of Paneth cell antimicrobial functions protects the host from microbiota dysbiosis and inflammation in the ileum2023 | Second Faculty of Medicine, Faculty of Science
- Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy2023 | First Faculty of Medicine, Second Faculty of Medicine
- NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on MRD-based protocol2023 | Second Faculty of Medicine
- Clinical outcomes, immunogenicity, and safety of BNT162b22 Vaccine in Primary Antibody Deficiency2023 | Second Faculty of Medicine
Loading network view...